Meta-analysisindependent cross-checkabstract only checked I-EGG-08 standard review

Eggs and type 2 diabetes: updated analysis

Egg consumption and risk of type 2 diabetes: findings from 3 large US cohort studies of men and women and a systematic review and meta-analysis of prospective cohort studies.

Overview

Drouin-Chartier JP et al.. Am J Clin Nutr 2020 · PMID 32453379 · DOI 10.1093/ajcn/nqaa115

No overall link; higher risk only in US studies.

Does the study support the specific claim? No · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Egg intake and T2D risk

How was the study done?

Three US cohorts plus meta-analysis of 16 cohorts

How many people, animals or samples were studied?

213,798 cohort participants (20,514 cases); meta-analysis 589,559 participants, 41,248 cases; US cohorts; global cohorts

What was actually found?

Cohorts: +1 egg/day HR +14% (7%-20%). Meta-analysis RR 1.07 (0.99-1.15), I2 69.8%; US 1.18 (1.10-1.27); Europe 0.99 (0.85-1.15); Asia 0.82 (0.62-1.09).

How large was the observed effect?

Cox; random effects

What do the results mean in everyday life?

Outside the US eggs were not linked to diabetes.

What are the study's limitations?

Heterogeneity

What does it say about Elawady's specific claim?

Contradicts general claim.

Do the results apply to Germany and Europe?

European studies null.

What can explicitly not be concluded from this study?

Cannot explain US finding.

Scientific in-depth review

1. Full reference

Authors
Drouin-Chartier JP et al.
Journal
Am J Clin Nutr
Year
2020
Identifier
PMID 32453379 DOI 10.1093/ajcn/nqaa115
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

None stated in record

2. Research question

Egg intake and T2D risk

3. Study design and population

Study design
Meta-analysis – Three US cohorts plus meta-analysis of 16 cohorts
Population

US cohorts; global cohorts

Country

USA; multinational

Period

1980-2017

Sample size

213,798 cohort participants (20,514 cases); meta-analysis 589,559 participants, 41,248 cases

Inclusion and exclusion criteria

Free of T2D, CVD, cancer

4. Methods and endpoints

Exposure / intervention

Egg intake

Comparator

per 1 egg/day

Endpoints

Incident T2D

Statistical methods

Cox; random effects

5. Actual results

Results

Cohorts: +1 egg/day HR +14% (7%-20%). Meta-analysis RR 1.07 (0.99-1.15), I2 69.8%; US 1.18 (1.10-1.27); Europe 0.99 (0.85-1.15); Asia 0.82 (0.62-1.09).

Absolute risks

not reported

Authors' conclusion

No overall association between moderate egg consumption and T2D; regional heterogeneity.

6. Strengths

  • Updated, registered

7. Weaknesses

  • Heterogeneity

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Simplified.

9. Assessment of the statistical interpretation

Overall null; US positive.

10. Relevance to the specific claim

C-EGG-07.

11. Independent contrary findings

US positive association.

12. Transferability to Germany and Europe

European studies null.

13. Overall methodological judgement

No overall association.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

US differences.

15. Linked fact checks